Ion-Exchange Displacement Chromatography: Scale-Up and Displacer Clearance for Recombinant Human Brain-Derived Neurotrophic Factor
Publication
Article
LCGC North AmericaNovember 1999
Volume 17
Issue 11
Pages: 1028–1035
Because of toxicity concerns and a lack of relevant case studies, displacement chromatography has yet to be embraced by the biotechnology industry. This article is an example of a protein displacement process used at the pilot scale.
LCGC 17(11), 1028–1035 (1999).Articles in this issue
Monoliths as Stationary Phases for Separating Biopolymers – Fourth-Generation Chromatography Sorbents
Automated DNA Fragment Analysis by High Performance Ultrathin-Layer Agarose Gel Electrophoresis
A Coin-Toss Experiment, Part II – Limits of the Analogy
Ion-Exchange Displacement Chromatography: Scale-Up and Displacer Clearance for Recombinant Human Brain-Derived Neurotrophic Factor
Readers' Question – Carryover, Mobile-Phase Temperature, and Column Care
Cleaning Validation
Recent Videos
Related Content
In-Loop Analyte Degradation in Two-Dimensional Liquid Chromatography: Example and Solutions
September 13th 2024Article
In this installment of “LC Troubleshooting,” we describe an artifact that can arise because of compound degradation during the transfer of fractions of the first dimension (1D) column effluent to the 2D separation.
